Beta Bionics hit net sales of $44.7m in the first nine months of 2024, marking an increase from $3.6m in 2023. Beta Bionics’ ...

A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe ...

Shares in the Irvine-based medical device company rose 29% to $23.64 and a $975 million market within the first three hours ...

“Rescinding the cap on insulin at $35 only makes pharmaceutical richer and everyday Americans, including MAGA voters, seriously poorer,” Steven Bechloss—author of the Substack, America, America — ...

President Donald Trump’s early action on health care reversed some of his predecessor’s policies, but former President Joe ...

A new formulation for medicine that does not need cold chain support, new air cargo friendly ultra-cold storage, and the FDA ...

DURHAM, N.C.and SEATTLE, Jan. 28, 2025 (GLOBE NEWSWIRE) -- . (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissue at ...

The FDA has approved Ozempic to reduce kidney failure risk in people with type 2 diabetes and chronic kidney disease. Studies ...

Beta Bionics, Inc. (BBNX) is planning to raise $112 million in an initial public offering on Thursday, January 30th, IPO Scoop reports. The company will be issuing 7,500,000 shares at $14.00-$16.00 ...